Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2010, Article ID 139020, 5 pages
http://dx.doi.org/10.1155/2010/139020
Review Article

Vascular Alterations and Sexual Function in Systemic Sclerosis

1Scleroderma Program, University of Michigan, 24 Frank Lloyd Wright Drive, Ann Arbor, MI 48106, USA
2Division of Rheumatology, University of Connecticut Health Center, MARB MC 5353 Room N3020, 263 Farmington Avenue, Farmington, CT 06034, USA

Received 11 May 2010; Accepted 8 July 2010

Academic Editor: Oliver Distler

Copyright © 2010 Ann Julie Impens and James R. Seibold. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Seibold, “Systemic sclerosis,” in Kelley's Textbook of Rheumatology, E. D. Harris et al., Ed., pp. 1279–1308, Elsevier Saunders, Philadelphia, Pa, USA, 2005. View at Google Scholar
  2. M. Proietti, A. Aversa, C. Letizia et al., “Erectile dysfunction in systemic sclerosis: effects of longterm inhibition of phosphodiesterase type-5 on erectile function and plasma endothelin-1 levels,” Journal of Rheumatology, vol. 34, no. 8, pp. 1712–1717, 2007. View at Google Scholar · View at Scopus
  3. S. C. Saad and A. E. Behrendt, “Scleroderma and sexuality,” Journal of Sex Research, vol. 33, no. 3, pp. 215–220, 1996. View at Google Scholar · View at Scopus
  4. L. M. Trilpell, P. J. Nietert, and A. N. Brown, “Prevalence of female sexual dysunction among women with systemic sclerosis,” in Proceedings of the 9th International Workshop on Scleroderma Research, Boston, Mass, USA, 2006.
  5. S. Bhadauria, D. K. Moser, P. J. Clements et al., “Genital tract abnormalities and female sexual function impairment in systemic sclerosis,” American Journal of Obstetrics and Gynecology, vol. 172, no. 2, pp. 580–587, 1995. View at Google Scholar · View at Scopus
  6. S. C. Saad, J. E. Pietrzykowski, S. S. Lewis et al., “Vaginal lubrication in women with scleroderma and Sjogren's syndrome,” Sexuality and Disability, vol. 17, no. 2, pp. 103–113, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Wilson, J. Goerzen, and M. J. Fritzler, “Treatment of sexual dysfunction in a patient with systemic sclerosis,” Journal of Rheumatology, vol. 20, no. 8, pp. 1446–1447, 1993. View at Google Scholar · View at Scopus
  8. M. A. Lotfi, J. Varga, and I. H. Hirsch, “Erectile dysfunction in systemic sclerosis,” Urology, vol. 45, no. 5, pp. 879–881, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Hong, J. E. Pope, J. M. Ouimet, E. Rullan, and J. R. Seibold, “Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis,” Journal of Rheumatology, vol. 31, no. 3, pp. 508–513, 2004. View at Google Scholar · View at Scopus
  10. U. A. Walker, A. Tyndall, and R. Ruszat, “Erectile dysfunction in systemic sclerosis,” Annals of the Rheumatic Diseases, vol. 68, no. 7, pp. 1083–1085, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. J. Impens, J. Rothman, E. Schiopu et al., “Sexual activity and functioning in female scleroderma patients,” Clinical and Experimental Rheumatology, vol. 27, no. 3, supplement 24, pp. S38–S43, 2009. View at Google Scholar · View at Scopus
  12. R. Knafo, B. D. Thombs, L. Jewett, M. Hudson, F. Wigley, and J. A. Haythornthwaite, “(Not) talking about sex: a systematic comparison of sexual impairment in women with systemic sclerosis and other chronic disease samples,” Rheumatology, vol. 48, no. 10, pp. 1300–1303, 2009. View at Google Scholar · View at Scopus
  13. A. A. Schouffoer, J. van der Marel, M. M. Ter Kuile et al., “Impaired sexual function in women with systemic sclerosis: a cross-sectional study,” Arthritis Care and Research, vol. 61, no. 11, pp. 1601–1608, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. “Impotence: NIH consensus development panel on impotence,” Journal of the American Medical Association, vol. 270, no. 1, pp. 83–90, 1993. View at Publisher · View at Google Scholar · View at Scopus
  15. E. V. Lally and S. A. Jimenez, “Impotence in progressive systemic sclerosis,” Annals of Internal Medicine, vol. 95, no. 2, pp. 150–153, 1981. View at Google Scholar · View at Scopus
  16. C. P. Simeon, V. Fonollosa, M. Vilardell, J. Ordi, R. Solans, and J. Lima, “Impotence and Peyronie's disease in systemic sclerosis,” Clinical and Experimental Rheumatology, vol. 12, no. 4, p. 464, 1994. View at Google Scholar · View at Scopus
  17. N. S. Nowlin, J. E. Brick, and D. J. Weaver, “Impotence in scleroderma,” Annals of Internal Medicine, vol. 104, no. 6, pp. 794–798, 1986. View at Google Scholar · View at Scopus
  18. S. Sukenik, J. Horowitz, D. Buskila, J. M. Abarbanel, L. Lismer, and I. Avinoach, “Impotence in systemic sclerosis,” Annals of Internal Medicine, vol. 106, no. 6, pp. 910–911, 1987. View at Google Scholar · View at Scopus
  19. A. Nehra, S. J. Hall, G. Basile et al., “Systemic sclerosis and impotence: a clinicopathological correlation,” Journal of Urology, vol. 153, no. 4, pp. 1140–1146, 1995. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Sukenik, J. M. Abarbanel, D. Buskila, G. Potashnik, and J. Horowitz, “Impotence, carpal tunnel syndrome and peripheral neuropathy as presenting symptoms in progressive systemic sclerosis,” Journal of Rheumatology, vol. 14, no. 3, pp. 641–643, 1987. View at Google Scholar · View at Scopus
  21. P. Ostojic and N. Damjanov, “The impact of depression, microvasculopathy, and fibrosis on development of erectile dysfunction in men with systemic sclerosis,” Clinical Rheumatology, vol. 26, no. 10, pp. 1671–1674, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Aversa, M. Proietti, R. Bruzziches, F. Salsano, and G. Spera, “The penile vasculature in systemic sclerosis: a duplex ultrasound study,” Journal of Sexual Medicine, vol. 3, no. 3, pp. 554–558, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Merla, G. L. Romani, A. Tangherlini et al., “Penile cutaneous temperature in systemic sclerosis: a thermal imaging study,” International Journal of Immunopathology and Pharmacology, vol. 20, no. 1, pp. 139–144, 2007. View at Google Scholar · View at Scopus
  24. R. Tamler and N. Bar-Chama, “Assessment of endothelial function in the patient with erectile dysfunction: an opportunity for the urologist,” International Journal of Impotence Research, vol. 20, no. 4, pp. 370–377, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. I. Eardley et al., “Pharmacotherapy for erectile dysfunction,” The Journal of Sexual Medicine, vol. 7, no. 1, pp. 524–540, 2010. View at Google Scholar
  26. R. C. Rosen and K. E. McKenna, “PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes,” Annual Review of Sex Research, vol. 13, pp. 36–88, 2002. View at Google Scholar · View at Scopus
  27. A. Aversa, E. Greco, R. Bruzziches, M. Pili, G. Rosano, and G. Spera, “Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study,” International Journal of Impotence Research, vol. 19, no. 2, pp. 200–207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. G. A. Bachmann and D. Avci, “Evaluation and management of female sexual dysfunction,” Endocrinologist, vol. 14, no. 6, pp. 337–345, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Basson, J. Berman, A. Burnett et al., “Report of the international consensus development conference on female sexual dysfunction: definitions and classifications,” Journal of Urology, vol. 163, no. 3, pp. 888–893, 2000. View at Google Scholar · View at Scopus
  30. S. Bhadauria, D. K. Moser, P. J. Clements et al., “Genital tract abnormalities and female sexual function impairment in systemic sclerosis,” American Journal of Obstetrics and Gynecology, vol. 172, no. 2, part 1, pp. 580–587, 1995. View at Google Scholar · View at Scopus
  31. P. D. Sampaio-Barros, A. M. Samara, and J. F. Marques Neto, “Gynaecologic history in systemic sclerosis,” Clinical Rheumatology, vol. 19, no. 3, pp. 184–187, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. M. L. Chivers and R. C. Rosen, “Phosphodiesterase type 5 inhibitors and female sexual response: faulty protocols or paradigms?” The Journal of Sexual Medicine, vol. 7, no. 2, pp. 858–872, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Mayer, C. G. Stief, M. C. Truss, and S. Ückert, “Phosphodiesterase inhibitors in female sexual dysfunction,” World Journal of Urology, vol. 23, no. 6, pp. 393–397, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Schiopu, V. M. Hsu, A. J. Impens et al., “Randomized placebo-controlled crossover trial of tadalafil in Raynaud's phenomenon secondary to systemic sclerosis,” Journal of Rheumatology, vol. 36, no. 10, pp. 2264–2268, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Rosen, C. Brown, J. Heiman et al., “The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function,” Journal of Sex and Marital Therapy, vol. 26, no. 2, pp. 191–208, 2000. View at Google Scholar · View at Scopus